Vtv Therapeutics Inc
About
Vtv Therapeutics Inc (NASDAQ:VTVT) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 7 2026
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Mar 16 2026
vTv Therapeutics to Participate in the 38th Annual ROTH Conference
Mar 10 2026
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 13 2026
vTv Therapeutics to Participate in Upcoming Investor Conferences
Feb 2 2026
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
Financials
Revenue
$17 K
Market Cap
$146.91 M
EPS
-3.20